Frontlight ResearchEarly access
CompletedNo phase
Repetitive Transcranial Magnetic Stimulation for Dementia
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Palo Alto, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 32 people enrolled
- Started
- 1 Jan 2016
- Ended
- 16 Sept 2025
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- RTMS
- sham
- Record updated
- 30 September 2025
Who can take part
- Age
- 55 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Veterans aged 55 years or older
- Diagnosed with Mild Cognitive Impairment (MCI) or dementia likely due to Alzheimer's disease
- Ability to obtain a Motor Threshold, determined during the screening process
- With an adequately stable condition and living environment to enable attendance at scheduled clinic visits
- If on a prescription medication for cognition that medication dose will be stable for at least 4 weeks prior to randomization into the study and participant will be willing to remain on a stable regimen during the acute treatment phase
- Able to read, verbalize understanding, and voluntarily sign the Informed Consent Form to be signed by the participant, or a designated legal representative when the participant lacks decision making capacity prior to participating in any study- specific procedures or assessments
Who cannot take part
- Patients with prior exposure to rTMS or electroconvulsive therapy (ECT)
- Unable to safely withdraw, at least two weeks prior to treatment commencement, from medications that substantially increase the risk of having seizures
- Current or Prior history of a seizure disorder as determined by patient report or chart review
- Participation in another concurrent interventional clinical trial
- Current or prior history of a mass lesion, cerebral infarct or other non-cognitive, active central nervous system (CNS) disease that would increase the risk for seizure
- Have a cardiac pacemaker or a cochlear implant
- Not fluent in English or a hearing impairment severe enough to impair comprehension
- Have an implanted device deep brain stimulation or metal in the brain
- Current substance abuse not including caffeine or nicotine as determined by patient report or chart review
- Active current suicidal intent or plan as determined by patient report or chart review
- Traumatic brain injury within the last two months
- Known current psychosis as determined by patient report or chart review
Where in United States
- VA Palo Alto Health Care System, Palo Alto, CAPalo Alto, United States
About the trial
What the trial wants to find out
The purpose is to is to study if repetitive transcranial magnetic stimulation (rTMS) improves cognitive function in patients with neurodegenerative conditions which may manifest as mild to moderate cognitive impairment and, in late phase, dementia. This study also intends to investigate if the responses to rTMS intervention are either positively or negatively correlated with the initial severity of cognitive impairment.
The 2 groups in the trial
- RTMSTreatment being tested
repetitive transcranial magnetic stimulation
- shamSham treatment, for comparison
sham noise to block the sound of treatment
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Repetitive Transcranial Magnetic Stimulation as a Treatment for Veterans with Cognitive Impairment and Multiple Comorbidities.Journal of Alzheimer's disease : JAD, 2022
- Record updated
- 30 September 2025